The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Levocetirizine Krka 5mg film-coated tablets

5 milligram(s) Film-coated tablet

Krka d.d., Novo mestoPA1347/043/001

Main Information

Trade NameLevocetirizine Krka 5mg film-coated tablets
Active SubstancesLevocetirizine dihydrochloride
Strength5 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderKrka d.d., Novo mesto
Licence NumberPA1347/043/001

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE09 levocetirizine


Licence Issued15/07/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0095-001-003
Interchangeable List DocumentPDF of Interchangeable List
« Back